Study Of Adjuvant Lapatinib In High-Risk Head And Neck Cancer Subjects After Surgery

PHASE3CompletedINTERVENTIONAL
Enrollment

688

Participants

Timeline

Start Date

December 31, 2006

Primary Completion Date

March 31, 2013

Study Completion Date

November 30, 2013

Conditions
Neoplasms, Head and Neck
Interventions
DRUG

Lapatinib

Dual ErbB1/2 inhibitor

RADIATION

Chemoradiation

Radiation plus platinum based chemotherapy

OTHER

Placebo

Placebo

Trial Locations (117)

6

GSK Investigational Site, Rathgar, Dublin

1000

GSK Investigational Site, Manila

1115

GSK Investigational Site, Budapest

1122

GSK Investigational Site, Budapest

1130

GSK Investigational Site, Vienna

1878

GSK Investigational Site, Quilmes

3000

GSK Investigational Site, Santa Fe

9700

GSK Investigational Site, Szombathely

10000

GSK Investigational Site, Zagreb

10003

GSK Investigational Site, New York

10330

GSK Investigational Site, Bangkok

10400

GSK Investigational Site, Bangkok

12462

GSK Investigational Site, Haidari, Athens

13419

GSK Investigational Site, Tallinn

14004

GSK Investigational Site, Córdoba

14033

GSK Investigational Site, Caen

15125

GSK Investigational Site, Athens

15706

GSK Investigational Site, Santiago de Compostela

16132

GSK Investigational Site, Genoa

17007

GSK Investigational Site, Girona

18014

GSK Investigational Site, Granada

18547

GSK Investigational Site, Neo Faliro

20132

GSK Investigational Site, Milan

20141

GSK Investigational Site, Milan

22300

GSK Investigational Site, Huesca

25198

GSK Investigational Site, Lleida

27100

GSK Investigational Site, Pavia

28033

GSK Investigational Site, Madrid

28034

GSK Investigational Site, Madrid

28040

GSK Investigational Site, Madrid

28041

GSK Investigational Site, Madrid

28046

GSK Investigational Site, Madrid

30008

GSK Investigational Site, Murcia

30122

GSK Investigational Site, Venezia

31052

GSK Investigational Site, Toulouse

32005

GSK Investigational Site, Ourense

34298

GSK Investigational Site, Montpellier

39008

GSK Investigational Site, Santander

41009

GSK Investigational Site, Seville

45122

GSK Investigational Site, Essen

46009

GSK Investigational Site, Valencia

49933

GSK Investigational Site, Angers

50009

GSK Investigational Site, Zaragoza

50200

GSK Investigational Site, Chiang Mai

51100

GSK Investigational Site, Reims

59000

GSK Investigational Site, Lille

62794

GSK Investigational Site, Springfield

63110

GSK Investigational Site, St Louis

65691

GSK Investigational Site, Brno

67085

GSK Investigational Site, Strasbourg

68024

GSK Investigational Site, Colmar

69008

GSK Investigational Site, Lyon

69120

GSK Investigational Site, Heidelberg

74000

GSK Investigational Site, Annecy

75970

GSK Investigational Site, Paris

76135

GSK Investigational Site, Karlsruhe

77150

GSK Investigational Site, Férolles-Attilly

79415

GSK Investigational Site, Lubbock

80131

GSK Investigational Site, Napoli

85025

GSK Investigational Site, La Roche-sur-Yon

92210

GSK Investigational Site, Saint-Cloud

94805

GSK Investigational Site, Villejuif

100021

GSK Investigational Site, Beijing

100036

GSK Investigational Site, Beijing

115478

GSK Investigational Site, Moscow

129128

GSK Investigational Site, Moscow

198255

GSK Investigational Site, Saint Petersburg

200032

GSK Investigational Site, Shanghai

300060

GSK Investigational Site, Tianjin

350014

GSK Investigational Site, Fuzhou

400012

GSK Investigational Site, Mumbai

411001

GSK Investigational Site, Pune

430030

GSK Investigational Site, Wuhan

450054

GSK Investigational Site, Ufa

510060

GSK Investigational Site, Guangzhou

682026

GSK Investigational Site, Kochi

695011

GSK Investigational Site, Trivandrum

27599-7600

GSK Investigational Site, Chapel Hill

C1185AAT

GSK Investigational Site, Ciudad Autonoma de Buenos Aires

S2000KZE

GSK Investigational Site, Rosario

A-6020

GSK Investigational Site, Innsbruck

A-6830

GSK Investigational Site, Rankweil

A-5020

GSK Investigational Site, Salzburg

A-1090

GSK Investigational Site, Vienna

T6G 1Z2

GSK Investigational Site, Edmonton

B3H 1V7

GSK Investigational Site, Halifax

N6A 4L6

GSK Investigational Site, London

G1R 2J6

GSK Investigational Site, Québec

J1H 5N4

GSK Investigational Site, Sherbrooke

10 000

GSK Investigational Site, Zagreb

775 20

GSK Investigational Site, Olomouc

708 52

GSK Investigational Site, Ostrava - Poruba

180 00

GSK Investigational Site, Prague

01067

GSK Investigational Site, Dresden

04103

GSK Investigational Site, Leipzig

06097

GSK Investigational Site, Halle

142 33

GSK Investigational Site, Athens

185 37

GSK Investigational Site, Peiraius

Unknown

GSK Investigational Site, Hong Kong

GSK Investigational Site, Kowloon

GSK Investigational Site, Galway

400 016

GSK Investigational Site, Mumbai

812 50

GSK Investigational Site, Bratislava

041 91

GSK Investigational Site, Košice

08025

GSK Investigational Site, Barcelona

08035

GSK Investigational Site, Barcelona

CB2 2QQ

GSK Investigational Site, Cambridge

HA6 2RN

GSK Investigational Site, Northwood

EH4 2XU

GSK Investigational Site, Edinburgh

BN2 5BE

GSK Investigational Site, Brighton

GU2 7XX

GSK Investigational Site, Guildford

NW1 2PG

GSK Investigational Site, London

SE1 7EH

GSK Investigational Site, London

SW3 6JJ

GSK Investigational Site, London

NE7 7DN

GSK Investigational Site, Newcastle upon Tyne

S10 2SJ

GSK Investigational Site, Sheffield

SM2 5PT

GSK Investigational Site, Sutton

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY